Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Vasculitis
ADR ID BADD_A04537
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.02      Vasculitides
10.02.02.006      Vasculitis
24      Vascular disorders
24.12      Vascular infections and inflammations
24.12.04      Vasculitides NEC
24.12.04.027      Vasculitis
Description A disorder characterized by inflammation involving the wall of a vessel. [CTCAE] Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. [MeSH]
MedDRA Code 10047115
MeSH ID D014657
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Angiitis | Digital vasculitis | Focal vasculitis | Panagiitis | Polyangiitis | Vasculitis | Vasculitis aggravated | Vasculitis legs | Vasculitis NOS | Vasculitis NOS aggravated | Vasculitis worsened | Granulomatous vasculitis | Ischaemic vasculitis | Ischemic vasculitis | Vasculitides | Angiitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00284Bortezomib0.000224%
BADD_D00305Bromocriptine mesylate--
BADD_D00306Budesonide0.000093%
BADD_D00318Busulfan--
BADD_D00344Canagliflozin0.000486%
BADD_D00347Candesartan cilexetil0.001262%
BADD_D00354Captopril--
BADD_D00356Carbamazepine0.000279%
BADD_D00376Caspofungin--
BADD_D00390Cefotaxime0.000049%
BADD_D00410Celecoxib0.000134%
BADD_D00412Cephalexin--
BADD_D00415Cerivastatin--
BADD_D00416Certolizumab pegol--
BADD_D00417Cetirizine--
BADD_D00424Cevimeline--
BADD_D00425Cevimeline hydrochloride--
BADD_D00442Chlorothiazide--
BADD_D00443Chlorothiazide sodium--
BADD_D00448Chlorthalidone--
BADD_D00471Ciprofloxacin--
BADD_D00472Ciprofloxacin hydrochloride--
BADD_D00474Cisplatin0.000112%
BADD_D00480Clarithromycin0.000558%
BADD_D00483Clindamycin0.000030%
BADD_D00501Clonazepam0.000045%
BADD_D00504Clopidogrel--
BADD_D00505Clopidogrel bisulfate--
BADD_D00510Cloxacillin--
BADD_D00511Clozapine--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 10 Pages
ADReCS-Target
ADR Term Drug Name Target